Express Scripts AI Market Strategy Report - Online Pharmacies

Answer Capsule

Express Scripts appears in 16.5% of AI observations across six platforms but converts only 2.45% of those appearances into valid recommendations, revealing a severe visibility-to-recommendation gap. The brand is present in AI responses primarily as a neutral reference rather than a recommended choice. Its strongest cluster is pricing and cost evaluation, where it captures $222,615 in monthly AI authority value, though nearly all of that derives from visibility assist rather than recommendation value. The clearest weakness is competitor displacement by Amazon Pharmacy and Cost Plus Drugs across every prompt cluster. The clearest opportunity is converting neutral mentions into positive recommendations by strengthening the public evidence layer around pricing transparency and service differentiation.

Who This Report Is For

This report is for pharmacy benefit managers, health plan executives, and digital health strategists evaluating how AI-driven discovery is reshaping shortlist formation in the online pharmacy category and where Express Scripts stands relative to competitors at the moment recommendations are formed.

Report Card

• Report type: AI Company Market Strategy Report
• Target company: Express Scripts
• Category / market studied: Online Pharmacies
• Reporting month: June 2026
• AI platforms tracked: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity
• Public high-intent clusters: 3 (Discovery and Evaluation, Comparison and Alternatives, Pricing and Cost Evaluation)
• AI observations analyzed: 1,431
• Competitors tracked: 10

Executive Summary

Express Scripts holds a moderate presence in AI-generated pharmacy responses but is not earning recommendation placement at a rate that matches its mention frequency. Across 1,431 observations spanning six AI platforms, Express Scripts appears in 236 responses, a raw mention presence rate of 16.5%. Of those appearances, only 35 qualify as valid recommendations, yielding a valid recommendation coverage rate of 2.45%. The brand earns 13 top-three placements and a single rank-one appearance across the entire dataset.

The gap between visibility and recommendation power is the central finding of this report. Express Scripts captures $517,375 in monthly AI authority value, but $463,346 of that derives from visibility assist rather than recommendation credit. Only $54,029 comes from actual recommendation placement. Expressed another way, 89.6% of the brand's AI authority value is generated by being mentioned neutrally, not by being recommended positively.

The pricing and cost evaluation cluster is Express Scripts' strongest area by authority value, at $222,615. The discovery and evaluation cluster follows at $167,951, and the comparison and alternatives cluster trails at $126,809. Across all clusters, the brand's net sentiment score of 0.178 reflects predominantly neutral framing with limited positive endorsement and zero negative mentions.

The strongest platform signal is Google AI Mode, where Express Scripts captures $243,183 in monthly AI authority value, though the bulk of that is visibility assist. Google AI Overviews follows at $144,402. The weakest platform is Perplexity, where the brand appears in only 7 observations and captures $2,534 in authority value. The Perplexity readout in the sentiment table reflects minimal public presence rather than active absence from the category.

At the competitive level, Amazon Pharmacy and Cost Plus Drugs are displacing Express Scripts in every cluster. In pricing prompts, where Express Scripts has its best relative performance, Cost Plus Drugs still captures $1.35 million compared to Express Scripts' $222,615. The brand is visible across platforms but is not being advanced as the recommended choice in the prompts that carry the most commercial weight.

Express Scripts' average recommended rank of 4.16 further illustrates the pattern. When the brand does earn recommendation credit, it is not appearing near the top of the shortlist. Combined with a rank-one rate of 0.07%, the evidence suggests the brand is being included as a supporting reference rather than a lead recommendation.

What Express Scripts Is Winning

Express Scripts' clearest win is its presence in the pricing and cost evaluation cluster. This cluster carries the highest buyer stage multiplier in the dataset at 1.5, reflecting decision-stage intent, and Express Scripts captures $222,615 in monthly AI authority value here. This is its strongest cluster across all three public prompt categories, and it indicates that AI systems recognize the brand in cost-related contexts.

The brand also shows zero negative mentions across all 236 observations and across all six platforms. A net sentiment score of 0.178 places Express Scripts above Optum Rx (0.07) and in line with CVS Pharmacy (0.17) and Walgreens (0.15). The absence of negative framing means the brand is not being characterized as a poor choice or cautionary example in AI responses, which is a baseline advantage that some competitors in the category do not share.

On Copilot and Google AI Overviews, Express Scripts shows its highest platform-level sentiment scores at 0.333 and 0.350 respectively. These are small samples, but they suggest pockets where positive framing is achievable rather than absent.

Where Express Scripts Has the Clearest AI Visibility Gaps

The most significant gap is recommendation conversion. Express Scripts appears in 236 observations but earns only 35 valid recommendations. Its valid recommendation coverage of 2.45% places it third from the bottom in the competitive set, ahead of only Optum Rx (0.56%) and just below Capsule (2.87%). A top-three rate of 0.91% and a rank-one rate of 0.07% confirm that the brand is not reaching the shortlist positions that drive buyer decisions.

Competitor displacement is consistent across all three clusters. In the discovery and evaluation cluster, Cost Plus Drugs captures $5.15 million in monthly AI authority value compared to Express Scripts' $167,951. In the comparison and alternatives cluster, Amazon Pharmacy captures $2.35 million versus Express Scripts' $126,809. In the pricing and cost evaluation cluster, where Express Scripts performs best, Cost Plus Drugs still leads at $1.35 million versus Express Scripts' $222,615. The brand is not being chosen in the prompts it is appearing in.

Platform-level gaps compound the recommendation problem. On ChatGPT, Express Scripts appears in 24 observations with a valid recommendation coverage of 0.81%. On Gemini, the brand appears in 44 observations but achieves only 0.068 on the sentiment score, the lowest platform-level score in its dataset, indicating that Gemini responses are treating Express Scripts almost entirely as neutral context. On Perplexity, 7 total observations and $2,534 in authority value reflect a minimal public presence that leaves the brand functionally absent from one of the fastest-growing AI discovery surfaces.

The neutral visibility rate of 13.56% is the clearest structural problem. The brand is referenced but not endorsed. In a market where AI-generated shortlists function as the first buyer filter, neutral mentions do not generate shortlist credit.

Biggest Opportunity

The clearest path from current performance to meaningful recommendation credit runs through the pricing and cost evaluation cluster. This is Express Scripts' strongest cluster by authority value, it carries the highest buyer-stage multiplier, and the brand already appears in pricing-related prompts. The conversion gap is not a visibility problem at this stage. It is a framing and evidence problem.

AI systems surfacing pricing prompts are recommending Cost Plus Drugs and Amazon Pharmacy because those brands have clear, citable, public evidence around pricing specificity, cost comparison data, and formulary transparency. Express Scripts operates a more complex model as a pharmacy benefit manager, but that complexity is not being translated into recommendation-ready language that AI systems can retrieve and synthesize into a positive recommendation.

Developing structured, citable content that explains Express Scripts' pricing model, cost-saving mechanisms, and formulary management outcomes in plain, comparable terms could shift AI responses from neutral references to positive recommendations in the cluster where the brand already has its highest presence. Given the 1.5 multiplier on decision-stage prompts, the authority value upside from even moderate improvement in this cluster is the largest available in the dataset.

Prompt Evidence

Google AI Mode / Pricing and Cost Evaluation Prompt: "What is the cheapest online pharmacy for maintenance medications?" Result: Express Scripts was mentioned neutrally as a PBM-affiliated option but was not recommended as a top choice. Cost Plus Drugs and Amazon Pharmacy received the recommendation placement.

ChatGPT / Discovery and Evaluation Prompt: "What are the best online pharmacies for prescription delivery?" Result: Express Scripts appeared in a list of pharmacy options but was not ranked or recommended. Amazon Pharmacy and Cost Plus Drugs were advanced as the top recommendations.

Copilot / Comparison and Alternatives Prompt: "Compare Express Scripts vs Amazon Pharmacy for prescription pricing" Result: Express Scripts was referenced as a comparison anchor but was not recommended. Amazon Pharmacy was positioned as the preferred option for consumer pricing.

Perplexity / Pricing and Cost Evaluation Prompt: "Which online pharmacy has the lowest prices for generic drugs?" Result: Express Scripts appeared in 1 observation with a neutral mention. Cost Plus Drugs and GoodRx received the recommendation placement.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map every prompt and platform where Express Scripts appears as a neutral mention versus a recommendation, identifying the specific sources and citation patterns that determine framing across all six platforms.

Phase 2: Recommendation Readiness Plan Identify the evidence gaps preventing AI systems from advancing Express Scripts from neutral reference to recommended choice, with priority on pricing and comparison prompts where the brand already has presence.

Phase 3: Owned Answer Layer Buildout Develop structured, citable content around Express Scripts' pricing model, formulary management outcomes, and service differentiators in a format that AI systems can retrieve and synthesize for recommendation responses.

Phase 4: Citation / Authority Layer Development Strengthen the public evidence layer across review platforms, comparison sites, and editorial content to increase the volume of positive, citable sources that AI systems can draw on when forming pharmacy recommendations.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track changes in mention rate, valid recommendation coverage, top-three placement, sentiment, and authority value across all platforms and clusters to measure progress and adjust strategy as AI model behavior evolves.

Why This Matters

Express Scripts is visible in AI responses but is not being chosen. In a market where AI-generated shortlists are becoming the first filter buyers encounter, neutral mentions do not produce shortlist credit. Competitors are capturing recommendation placement in the same prompts where Express Scripts appears only as context. The gap between a 16.5% mention presence rate and a 2.45% valid recommendation coverage rate represents the commercial risk in the current position.

The pricing and cost evaluation cluster offers the most concentrated opportunity. Express Scripts already has a presence there. The evidence layer that AI systems need to advance the brand from a neutral reference to a positive recommendation is buildable. The next move is not to increase visibility broadly. It is to convert existing visibility into recommendation credit where buyer intent is highest.

Core Metrics

• Mentions: 236
• Valid recommendations: 35
• Top 3 recommendation count: 13
• Rank #1 recommendation count: 1
• Average recommended rank: 4.16
• Positive mentions: 42
• Neutral mentions: 194
• Negative mentions: 0
• Raw mention presence rate: 16.5%
• Valid recommendation coverage: 2.45%
• Top 3 recommendation rate: 0.91%
• Rank #1 recommendation rate: 0.07%
• Strongest cluster by recommendation behavior: Pricing and Cost Evaluation
• Strongest platform by recommendation behavior: Google AI Mode

Sentiment Score

Sentiment Score = (positive mentions x 1 + neutral mentions x 0 + negative mentions x -1) / total mentions

Sentiment Score = (42 x 1 + 194 x 0 + 0 x -1) / 236 = 42 / 236 = 0.178

This score means Express Scripts receives predominantly neutral framing in AI responses. The 194 neutral mentions out of 236 total appearances indicate the brand is referenced as factual context rather than endorsed as a recommendation. Unclassified mention counts would misrepresent performance because they would treat a neutral reference as equivalent to a positive recommendation. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal outcomes. Counting all mentions as wins is bad measurement. Classified sentiment is required before any AI visibility data can be meaningfully interpreted.

Sentiment by Platform

Methodology

1. This report is a benchmark-based AI company market strategy report, not a client implementation case study. Findings reflect publicly observable AI recommendation behavior and should not be interpreted as confirmed business outcomes.
2. Reporting window: June 2026, snapshot-based collection. AI outputs can change with model updates, data source changes, and prompt variation.
3. AI platforms tracked: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, and Perplexity. Platform-specific findings reflect the data present in this dataset only.
4. Observations analyzed: 1,431 total across all platforms and clusters. Individual prompt count was not provided in the source dataset. Unique prompt count is unavailable in this public version.
5. Competitor universe: Amazon Pharmacy, Capsule, Cost Plus Drugs, CVS Pharmacy, Express Scripts, GoodRx, Honeybee Health, Optum Rx, PillPack, and Walgreens. This universe covers major category types but is not a full market census.
6. Public high-intent clusters: Best Online Pharmacy Discovery and Evaluation (consideration stage), Online Pharmacy Comparison and Alternatives (evaluation stage), and Online Pharmacy Pricing and Cost Evaluation (decision stage). Cluster labels reflect buyer intent staging and carry multipliers of 1.0, 1.25, and 1.5 respectively in the modeled value framework.
7. Definition of a mention: A mention is recorded when a company name or brand appears in an AI-generated response, regardless of sentiment, ranking, or recommendation status.
8. Definition of a valid recommendation: A valid recommendation is a positive, shortlist-quality appearance that earns recommendation credit. Neutral references, cautionary mentions, and comparison anchors do not qualify as valid recommendations. This distinction is the foundation of the analysis.
9. Metrics used: Raw mention presence rate, valid recommendation coverage, top-three recommendation rate, rank-one recommendation rate, average recommended rank, net sentiment score, monthly AI authority value, monthly AI recommendation value, monthly AI visibility assist value, and captured share of AI opportunity.
10. Modeled value interpretation: Monthly AI authority value, recommendation value, and visibility assist value are modeled benchmark estimates based on commercial intent proxies and platform weighting. They are not revenue, pipeline, or booked demand figures and should not be interpreted as such.
11. Ahrefs data handling: Where traditional search and source layer data is referenced, it is used only as supporting evidence for organic visibility, backlink strength, and public evidence retrievability. Ahrefs data does not override AI recommendation metrics and does not independently prove AI recommendation influence.
12. Limitations: This is a point-in-time benchmark. AI system behavior changes with model updates and data source shifts. The competitor universe does not represent the full online pharmacy market. Modeled values are estimates. This report is not a full audit.

See How AI Is Recommending Your Brand

The benchmark shows where Express Scripts and the broader online pharmacy category stand across six AI platforms, but every brand has a different recommendation profile depending on its prompt clusters, citation sources, and public evidence layer. CiteWorks Studio can map where your brand is being mentioned versus where it is being recommended, identify the specific prompts and platforms where competitors are being chosen instead, and show what the public evidence layer needs to support stronger recommendation-stage visibility.